<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01035489</url>
  </required_header>
  <id_info>
    <org_study_id>2009/1991</org_study_id>
    <nct_id>NCT01035489</nct_id>
  </id_info>
  <brief_title>Trial in Cardiac Resynchronization Therapy (CRT): Right Ventricular Apex Versus High Posterior Septum</brief_title>
  <official_title>Echocardiographic Dyssynchrony in Heart Failure in CRT; Right Ventricular Apex v.s. High Posterior Septum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Haukeland University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In heart failure patients we hypothesised that right ventricular high posterior septum is
      superior to right ventricular apex in CRT and DDD pacemaker. In two separate trials we
      prospectively randomized the right ventricular lead placement to find evidence of differences
      in heart failure symptoms (NYHA-class), 6 minute hall walk and echocardiographic measurements
      of reverse remodelling and dyssynchrony.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">June 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Echocardiographic reverse remodelling and dyssynchrony</measure>
    <time_frame>3, 6, 12, 18 and 24 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">85</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>CRT; RV apical lead placement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Right ventricular apical lead placement in CRT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CRT; RV high posterior septum</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High posterior septal lead placement in CRT</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CRT in heart failure; Right ventricular apex v.s. high posterior septum</intervention_name>
    <description>RV lead is randomized to either apex or high posterior septum</description>
    <arm_group_label>CRT; RV apical lead placement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CRT in heart failure; Right ventricular apex v.s. high posterior septum</intervention_name>
    <description>RV lead is randomized to either apex or high posterior septum</description>
    <arm_group_label>CRT; RV high posterior septum</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CRT:

               -  LVEF &lt; 35%

               -  LVEDD &gt; 5.5 cm

               -  NYHA 3-4

               -  QRS &gt; 120 ms

               -  Optimal medical treatment

               -  Both CRT-pacemakers (CRT-P) and CRT combined with ICD (CRT-D)

        Exclusion Criteria:

          -  Not fulfilling inclusion criteria or not written consensus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Svein Faerestrand, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faerestrand S</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <zip>5021</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2009</study_first_submitted>
  <study_first_submitted_qc>December 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2009</study_first_posted>
  <last_update_submitted>May 23, 2011</last_update_submitted>
  <last_update_submitted_qc>May 23, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 24, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof. Svein Faerestrand</name_title>
    <organization>Haukeland University Hospital, Dept. of Heart Disease, 5021 Bergen, Norway</organization>
  </responsible_party>
  <keyword>Pacemaker treatment in heart failure</keyword>
  <keyword>Cardiac resynchronization therapy</keyword>
  <keyword>DDD pacemakers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

